Concurrently, it was found that the numbers of mature DCs in inguinal lymph nodes and CD3 + CD8 + T cells and CD3 + CD4 + T cells in tumors were increased significantly, indicating that this treatment could activate the systematic anti‐tumor immune responses. This evidence concerns the gene CD8A and neoplasm.